Webinar "The Complex Goal of Moving Immunotherapy of HCC Into Earlier Scenarios"

Tuesday, November 19th, 2024 at 3pm CET

Webinar Chairs:

• Peter Galle, Univ.-Prof. and Director, University Medical Center Mainz, Germany
• Marco Sanduzzi, Research Fellow, Barcelona Clinic Liver Cancer Group, Hospital Clinic, Spain

Webinar Speakers:

• "Immunotherapy in Embolization-Eligible HCC" by Ricardo Lencioni,  MD, Professor of Radiology and Program Director University of Pisa School of Medicine, Italy
• "Immunotherapy in Resectable HCC" by speaker to be confirmed.